Hasil Pencarian - Hongbing Huang
- Menampilkan 1 - 10 hasil dari 10
-
1
-
2
Unconfined compressive strength prediction of rock materials based on machine learning oleh Lihong Niu, Qiang Cui, Jiangyun Luo, Hongbing Huang, Jing Zhang
Diterbitkan 2024-06-01
Artikel -
3
-
4
-
5
-
6
Landscape of clinical drug development of ADCs used for the pharmacotherapy of cancers: an overview of clinical trial registry data from 2002 to 2022 oleh Wenjing Zhou, Zhiyuan Xu, Shu Liu, Xiaohuan Lou, Pengcheng Liu, Huali Xie, Shuiyan Zhang, Xi Liu, Baoshan Zhuo, Hongbing Huang
Diterbitkan 2024-07-01
Artikel -
7
Retraction Note: N6-methyladenosine induced mir-143-3p promotes the brain metastasis of lung cancer via regulation of VASH1 oleh Hongsheng Wang, Qianqian Deng, Ziyan Lv, Yuyi Ling, Xue Hou, Zhuojia Chen, Xiaoxiao Dinglin, Shuxiang Ma, Delan Li, Yingmin Wu, Yanxi Peng, Hongbing Huang, Likun Chen
Diterbitkan 2023-08-01
Artikel -
8
RETRACTED ARTICLE: N6-methyladenosine induced miR-143-3p promotes the brain metastasis of lung cancer via regulation of VASH1 oleh Hongsheng Wang, Qianqian Deng, Ziyan Lv, Yuyi Ling, Xue Hou, Zhuojia Chen, Xiaoxiao Dinglin, Shuxiang Ma, Delan Li, Yingmin Wu, Yanxi Peng, Hongbing Huang, Likun Chen
Diterbitkan 2019-12-01
Artikel -
9
Rituximab exposure‐response in triweekly R‐CHOP treatment in DLBCL: A loading dose is recommended to improve clinical outcomes oleh Shu Liu, Zhao Wang, Rongxin Chen, He Huang, Xueding Wang, Chen Peng, Yanping Guan, Xiaojie Fang, Shaoxing Guan, Hongbing Huang, Tao Liu, Tongyu Lin, Min Huang
Diterbitkan 2022-03-01
Artikel -
10
A Cost-Effectiveness Analysis: First-Line Avelumab Plus Axitinib Versus Sunitinib for Advanced Renal-Cell Carcinoma oleh Peiyao Lu, Weiting Liang, Jiahao Li, Yanming Hong, Zhuojia Chen, Tao Liu, Pei Dong, Hongbing Huang, Tiantian Zhang, Tiantian Zhang, Jie Jiang, Jie Jiang, Jie Jiang
Diterbitkan 2020-05-01
Artikel